$9.91
-0.21-2.08%
At close: -
$9.91
0.000.00%
After Hours: 4:00 PM EDT
Comments
Loading...
Certara Insider Trading Activity | NASDAQ:CERT | Benzinga
Track the latest Certara insider trading activity. Stay informed on recent buys, sells, and market impact for Certara stock.
What is Insider Activity?
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
What are Certara Inc Insiders Doing?
Insiders have report no purchases/sales in the last 30 days.
Notable Recent Insider Buys and Sales
There has been no Insider buying or selling in the last 90 days.
Ownership Statistics for Certara Inc
Shares Outstanding
161.018M
Insider Shares Owned
6.635M
Insider Percentage Owned
4.12%
Institutional Shares Held
78.303M
Institutional Percentage Held
48.6%
| Oct 08, 2024 | Patrick F Smith | PRESIDENT, DRUG DEV SOLUTIONS | -5.41K | $11.03 | -$59.66K | SELL | -9.75% | 50.09K | Oct 07 | View |
| Sep 10, 2024 | Leif E Pedersen | PRESIDENT, CHIEF COMMERCAL OFF | -51.22K | $11.29 | -$578.32K | SELL | -33.94% | 99.70K | Sep 09 | View |
| Apr 04, 2024 | Patrick F Smith | PRESIDENT, DRUG DEV SOLUTIONS | -14.43K | $16.85 | -$243.16K | SELL | -22.36% | 50.09K | Apr 02 | View |
| Apr 03, 2024 | Richard M Traynor | SVP AND GENERAL COUNSEL | 4.05K | $17.92 | -$165.64K | SELL-OPTIONS | 2.39% | 173.52K | Apr 01 | View |
| Mar 05, 2024 | Richard M Traynor | SVP AND GENERAL COUNSEL | -3.00K | $18.28 | -$54.84K | SELL | -1.81% | 162.37K | Mar 04 | View |
| Feb 21, 2024 | Patrick F Smith | PRESIDENT, DRUG DEV SOLUTIONS | -5.00K | $18.00 | -$90.00K | SELL | -8.34% | 54.98K | Feb 20 | View |
| Feb 14, 2024 | Richard M Traynor | SVP AND GENERAL COUNSEL | -6.00K | $18.00 | -$108.00K | SELL | -3.50% | 165.37K | Feb 12 | View |
| Dec 27, 2023 | Richard M Traynor | SVP AND GENERAL COUNSEL | -6.00K | $18.00 | -$108.00K | SELL | -3.38% | 171.37K | Dec 26 | View |
| Sep 12, 2023 | Leif E Pedersen | PRESIDENT, CHIEF COMMERCAL OFF | -51.22K | $14.60 | -$747.87K | SELL | -28.44% | 128.88K | Sep 11 | View |
| Aug 23, 2023 | Eran Broshy | — | 5.00K | $15.81 | $79.06K | BUY | 53.42% | 14.36K | Aug 21 - Aug 22 | View |
| Jun 06, 2023 | Patrick F Smith | PRESIDENT, INTEGRATED DRUG DEV | -19.10K | $21.55 | -$411.69K | SELL | -24.16% | 59.98K | Jun 05 | View |
| May 15, 2023 | Richard M Traynor | SVP AND GENERAL COUNSEL | -5.00K | $20.82 | -$104.10K | SELL | -2.74% | 177.37K | May 11 | View |
| Apr 17, 2023 | Richard M Traynor | SVP AND GENERAL COUNSEL | -5.00K | $23.66 | -$118.30K | SELL | -2.67% | 182.37K | Apr 14 | View |
| Mar 07, 2023 | Richard M Traynor | SVP AND GENERAL COUNSEL | -10.00K | $21.45 | -$214.50K | SELL | -5.14% | 184.56K | Mar 06 | View |
| Feb 03, 2023 | Richard M Traynor | SVP AND GENERAL COUNSEL | -15.00K | $20.00 | -$300.00K | SELL | -7.16% | 194.56K | Feb 02 | View |
| Dec 12, 2022 | EQT Avatar Parent LPEQT Avatar Parent GP LLCEQT Fund Management Sa rl | 10% OWNER | -29.95M | $15.00 | -$449.32M | SELL | -100.00% | 0.00 | Dec 08 | View |
| Nov 23, 2022 | Leif E Pedersen | PRESIDENT, SOFTWARE | -51.22K | $15.55 | -$796.52K | SELL | -22.59% | 175.50K | Nov 22 | View |
| Nov 16, 2022 | Mason P Slaine | — | -250.00K | $15.56 | -$3.89M | SELL | -27.46% | 660.32K | Nov 14 - Nov 15 | View |
| Nov 15, 2022 | Matthew M Walsh | — | -12.06K | $14.74 | -$177.75K | SELL | -6.70% | 167.90K | Nov 14 | View |
| Nov 14, 2022 | Patrick F Smith | PRESIDENT, INTEGRATED DRUG DEV | -2.39K | $13.48 | -$32.18K | SELL | -3.09% | 74.86K | Nov 09 | View |
| Aug 23, 2022 | Stephen M McLean | — | 20.00K | $16.32 | $326.40K | BUY | 90.91% | 42.00K | Aug 19 | View |
| Aug 18, 2022 | Michael Andrew Schemick | CHIEF FINANCIAL OFFICER | 25.00K | $16.64 | $416.00K | BUY | 5.07% | 517.87K | Aug 17 | View |
| Aug 18, 2022 | Patrick F Smith | PRESIDENT, INTEGRATED DRUG DEV | -10.00K | $17.71 | -$177.10K | SELL | -11.30% | 78.49K | Aug 16 | View |
| Aug 17, 2022 | EQT Avatar Parent LPEQT Avatar Parent GP LLCEQT Fund Management Sa rl | 10% OWNER | -6.00M | $17.38 | -$104.36M | SELL | -16.70% | 29.95M | Aug 16 | View |
| Aug 17, 2022 | Mason P Slaine | DIRECTOR | -182.47K | $17.38 | -$3.17M | SELL | -16.70% | 910.32K | Aug 16 | View |
| Jun 09, 2022 | Patrick F Smith | PRESIDENT, INTEGRATED DRUG DEV | -10.00K | $19.16 | -$191.60K | SELL | -10.15% | 88.49K | Jun 08 | View |
| Jun 03, 2022 | Mason P Slaine | — | -250.00K | $19.56 | -$4.89M | SELL | -18.62% | 1.09M | Jun 02 | View |
| Jun 01, 2022 | EQT Avatar Parent LPEQT Avatar Parent GP LLCEQT Fund Management Sa rl | 10% OWNER | -1.50M | $19.00 | -$28.50M | SELL | -4.00% | 35.96M | May 31 | View |
| Apr 05, 2022 | Patrick F Smith | PRESIDENT, INTEGRATED DRUG DEV | -4.88K | $22.04 | -$107.62K | SELL | -4.72% | 98.49K | Apr 01 - Apr 04 | View |
| Mar 18, 2022 | Richard M Traynor | SVP AND GENERAL COUNSEL | -3.00K | $20.00 | -$60.00K | SELL | -1.40% | 211.29K | Mar 16 | View |
| Mar 18, 2022 | Mason P Slaine | — | -250.00K | $20.21 | -$5.05M | SELL | -15.70% | 1.34M | Mar 16 - Mar 17 | View |
| Mar 17, 2022 | William F Feehery | CHIEF EXECUTIVE OFFICER | -62.48K | $20.17 | -$1.26M | SELL | -2.79% | 2.18M | Mar 16 | View |
| Mar 14, 2022 | William F Feehery | CHIEF EXECUTIVE OFFICER | -27.52K | $20.29 | -$558.28K | SELL | -1.21% | 2.24M | Mar 11 | View |
| Feb 22, 2022 | William F Feehery | CHIEF EXECUTIVE OFFICER | -75.00K | $23.35 | -$1.75M | SELL | -3.20% | 2.27M | Feb 18 | View |
| Feb 22, 2022 | William F Feehery | CHIEF EXECUTIVE OFFICER | -90.00K | $24.32 | -$2.19M | SELL | -3.70% | 2.34M | Feb 17 | View |
| Feb 02, 2022 | Mason P Slaine | — | -50.00K | $26.61 | -$1.33M | SELL | -3.04% | 1.59M | Feb 01 | View |
| Jan 27, 2022 | Richard M Traynor | SVP AND GENERAL COUNSEL | -3.00K | $26.01 | -$78.03K | SELL | -1.38% | 214.29K | Jan 26 | View |
| Jan 27, 2022 | William F Feehery | CHIEF EXECUTIVE OFFICER | -75.00K | $25.37 | -$1.90M | SELL | -2.99% | 2.43M | Jan 26 | View |
| Jan 21, 2022 | Justin Edge | PRES., REGULATORY & ACCESS | -5.00K | $27.50 | -$137.50K | SELL | -1.24% | 397.09K | Jan 20 | View |
| Jan 20, 2022 | Richard M Traynor | SVP AND GENERAL COUNSEL | -5.00K | $27.44 | -$137.20K | SELL | -2.25% | 217.29K | Jan 18 | View |
| Jan 04, 2022 | Mason P Slaine | — | -50.00K | $28.63 | -$1.43M | SELL | -2.95% | 1.64M | Jan 03 | View |
| Dec 28, 2021 | Richard M Traynor | SVP AND GENERAL COUNSEL | -3.00K | $29.30 | -$87.90K | SELL | -1.33% | 222.29K | Dec 27 | View |
| Dec 27, 2021 | James E. Cashman III | — | -25.11K | $29.20 | -$733.24K | SELL | -5.41% | 438.78K | Dec 23 | View |
| Dec 23, 2021 | James E. Cashman III | — | -19.89K | $29.00 | -$576.78K | SELL | -4.11% | 463.89K | Dec 22 | View |
| Dec 23, 2021 | William F Feehery | CHIEF EXECUTIVE OFFICER | -75.00K | $28.58 | -$2.14M | SELL | -2.90% | 2.51M | Dec 22 | View |
| Dec 21, 2021 | Jieun W Choe | CHIEF STRATEGY & MARKETING | -7.50K | $28.00 | -$210.00K | SELL | -2.91% | 250.49K | Dec 20 | View |
| Dec 20, 2021 | Jieun W Choe | CHIEF STRATEGY & MARKETING | -5.00K | $26.13 | -$130.65K | SELL | -1.90% | 257.99K | Dec 17 | View |
| Dec 14, 2021 | Mason P Slaine | — | -50.00K | $28.05 | -$1.40M | SELL | -2.87% | 1.69M | Dec 13 | View |
| Dec 08, 2021 | William F Feehery | CHIEF EXECUTIVE OFFICER | -70.00K | $27.77 | -$1.94M | SELL | -2.64% | 2.58M | Dec 07 | View |
| Dec 06, 2021 | William F Feehery | CHIEF EXECUTIVE OFFICER | -70.00K | $26.02 | -$1.82M | SELL | -2.57% | 2.65M | Dec 03 | View |
| Nov 26, 2021 | William F Feehery | CHIEF EXECUTIVE OFFICER | -145.00K | $28.43 | -$4.12M | SELL | -5.06% | 2.72M | Nov 24 | View |
| Nov 24, 2021 | Mason P Slaine | DIRECTOR | -376.15K | $29.74 | -$11.19M | SELL | -17.75% | 1.74M | Nov 22 | View |
| Nov 24, 2021 | EQT Avatar Parent LPEQT Avatar Parent GP LLCEQT Fund Management Sa rl | 10% OWNER | -8.12M | $29.74 | -$241.43M | SELL | -17.81% | 37.46M | Nov 22 | View |
| Nov 22, 2021 | William F Feehery | CHIEF EXECUTIVE OFFICER | -70.00K | $30.31 | -$2.12M | SELL | -2.38% | 2.87M | Nov 19 | View |
| Nov 22, 2021 | Jieun W Choe | CHIEF STRATEGY & MARKETING | -20.00K | $30.30 | -$606.00K | SELL | -7.07% | 262.99K | Nov 19 | View |
| Nov 16, 2021 | Michael Andrew Schemick | CHIEF FINANCIAL OFFICER | -66.67K | $37.84 | -$2.52M | SELL | -11.83% | 496.84K | Nov 15 | View |
| Nov 16, 2021 | Richard M Traynor | SVP AND GENERAL COUNSEL | -73.00K | $37.98 | -$2.77M | SELL | -24.47% | 225.29K | Nov 15 | View |
| Nov 15, 2021 | Robert Aspbury | PRESIDENT, SIMCYP | -21.55K | $39.56 | -$852.77K | SELL | -7.17% | 278.97K | Nov 11 | View |
| Oct 28, 2021 | William F Feehery | CHIEF EXECUTIVE OFFICER | -75.00K | $39.24 | -$2.94M | SELL | -2.49% | 2.94M | Oct 27 | View |
| Oct 27, 2021 | Richard M Traynor | SVP AND GENERAL COUNSEL | -3.00K | $39.95 | -$119.85K | SELL | -1.00% | 298.29K | Oct 26 | View |
| Oct 27, 2021 | Justin Edge | PRES., REGULATORY & ACCESS | -3.00K | $39.95 | -$119.85K | SELL | -0.74% | 402.09K | Oct 26 | View |
| Oct 22, 2021 | Justin Edge | PRES., REGULATORY & ACCESS | -6.12K | $38.60 | -$236.08K | SELL | -1.49% | 405.09K | Oct 21 | View |
| Oct 21, 2021 | Justin Edge | PRES., REGULATORY & ACCESS | -12.67K | $38.58 | -$488.96K | SELL | -2.99% | 411.21K | Oct 20 | View |
| Oct 20, 2021 | Jieun W Choe | CHIEF STRATEGY & MARKETING | -20.00K | $38.08 | -$761.62K | SELL | -6.60% | 282.99K | Oct 19 | View |
| Oct 20, 2021 | Justin Edge | PRES., REGULATORY & ACCESS | -1.21K | $38.55 | -$46.65K | SELL | -0.28% | 423.88K | Oct 19 | View |
| Oct 19, 2021 | Michael Andrew Schemick | CHIEF FINANCIAL OFFICER | -66.67K | $36.48 | -$2.43M | SELL | -10.58% | 563.51K | Oct 18 | View |
| Oct 18, 2021 | Richard M Traynor | SVP AND GENERAL COUNSEL | -5.00K | $37.38 | -$186.90K | SELL | -1.63% | 301.29K | Oct 15 | View |
| Oct 18, 2021 | Justin Edge | PRES., REGULATORY & ACCESS | -5.00K | $37.38 | -$186.90K | SELL | -1.16% | 425.09K | Oct 15 | View |
| Oct 04, 2021 | Robert Aspbury | PRESIDENT, SIMCYP | -19.35K | $33.51 | -$648.58K | SELL | -6.05% | 300.52K | Oct 01 | View |
| Sep 28, 2021 | Justin Edge | PRES., REGULATORY & ACCESS | -3.00K | $36.00 | -$108.00K | SELL | -0.69% | 430.09K | Sep 27 | View |
| Sep 28, 2021 | Richard M Traynor | SVP AND GENERAL COUNSEL | -3.00K | $36.00 | -$108.00K | SELL | -0.97% | 306.29K | Sep 27 | View |
| Sep 23, 2021 | William F Feehery | CHIEF EXECUTIVE OFFICER | -75.00K | $36.37 | -$2.73M | SELL | -2.43% | 3.01M | Sep 22 | View |
| Sep 21, 2021 | Michael Andrew Schemick | CHIEF FINANCIAL OFFICER | -66.67K | $34.62 | -$2.31M | SELL | -9.57% | 630.18K | Sep 20 | View |
| Sep 20, 2021 | Jieun W Choe | CHIEF STRATEGY & MARKETING | -20.00K | $35.76 | -$715.19K | SELL | -6.19% | 302.99K | Sep 17 | View |
| Sep 14, 2021 | EQT Avatar Parent LPEQT Avatar Parent GP LLCEQT Fund Management Sa rl | 10% OWNER | -13.39M | $29.80 | -$399.15M | SELL | -22.71% | 45.58M | Sep 13 | View |
| Sep 14, 2021 | Mason P Slaine | — | -620.67K | $29.80 | -$18.50M | SELL | -22.66% | 2.12M | Sep 13 | View |
| Sep 10, 2021 | Leif E Pedersen | PRESIDENT, SOFTWARE | -51.22K | $34.50 | -$1.77M | SELL | -18.30% | 228.71K | Sep 09 | View |
| Sep 07, 2021 | Craig R. Raynor | PRESIDENT, INTEGRATED DRUG DEV | -54.46K | $36.33 | -$1.98M | SELL | -14.70% | 316.01K | Sep 02 | View |
| Sep 02, 2021 | Robert Aspbury | PRESIDENT, SIMCYP | -19.35K | $33.78 | -$653.78K | SELL | -5.71% | 319.88K | Sep 01 | View |
| Sep 02, 2021 | Richard M Traynor | SVP AND GENERAL COUNSEL | -30.00K | $33.80 | -$1.01M | SELL | -8.84% | 309.29K | Sep 01 | View |
| Sep 01, 2021 | Justin Edge | PRES., REGULATORY & ACCESS | -9.00K | $33.50 | -$301.50K | SELL | -2.04% | 433.09K | Aug 30 | View |
| Aug 26, 2021 | William F Feehery | CHIEF EXECUTIVE OFFICER | -75.00K | $31.28 | -$2.35M | SELL | -2.37% | 3.09M | Aug 25 | View |
| Aug 25, 2021 | Jieun W Choe | CHIEF STRATEGY & MARKETING | -7.50K | $30.00 | -$225.00K | SELL | -2.27% | 322.99K | Aug 24 | View |
| Aug 23, 2021 | Jieun W Choe | CHIEF STRATEGY & MARKETING | -12.50K | $28.34 | -$354.25K | SELL | -3.64% | 330.49K | Aug 19 | View |
| Aug 17, 2021 | Richard M Traynor | SVP AND GENERAL COUNSEL | -8.00K | $28.58 | -$228.64K | SELL | -2.30% | 339.29K | Aug 16 | View |
| Aug 17, 2021 | Michael Andrew Schemick | CHIEF FINANCIAL OFFICER | -66.67K | $28.22 | -$1.88M | SELL | -8.73% | 696.84K | Aug 16 | View |
| Aug 17, 2021 | Justin Edge | PRES., REGULATORY & ACCESS | -5.00K | $28.58 | -$142.90K | SELL | -1.12% | 442.09K | Aug 16 | View |
| Aug 13, 2021 | Robert Aspbury | PRESIDENT, SIMCYP | -19.35K | $27.54 | -$533.01K | SELL | -5.40% | 339.23K | Aug 11 | View |
| Aug 02, 2021 | EQT Avatar Parent LPEQT Avatar Parent GP LLCEQT Fund Management Sa rl | 10% OWNER | -7.25M | $26.00 | -$188.57M | SELL | -10.95% | 58.97M | Aug 02 | View |
| Jul 30, 2021 | William F Feehery | CHIEF EXECUTIVE OFFICER | -75.00K | $26.16 | -$1.96M | SELL | -2.32% | 3.16M | Jul 28 | View |
| Jul 27, 2021 | Richard M Traynor | SVP AND GENERAL COUNSEL | -3.00K | $26.27 | -$78.81K | SELL | -0.86% | 347.29K | Jul 26 | View |
| Jul 21, 2021 | Michael Andrew Schemick | CHIEF FINANCIAL OFFICER | -66.67K | $24.37 | -$1.62M | SELL | -8.03% | 763.51K | Jul 19 | View |
| Jul 06, 2021 | Robert Aspbury | PRESIDENT, SIMCYP | -19.35K | $28.03 | -$542.49K | SELL | -5.12% | 358.58K | Jul 01 | View |
| Jun 29, 2021 | Richard M Traynor | SVP AND GENERAL COUNSEL | -3.00K | $28.38 | -$85.14K | SELL | -0.85% | 350.29K | Jun 28 | View |
| Jun 28, 2021 | Richard M Traynor | SVP AND GENERAL COUNSEL | -5.00K | $26.37 | -$131.85K | SELL | -1.40% | 353.29K | Jun 24 | View |
| Jun 24, 2021 | William F Feehery | CHIEF EXECUTIVE OFFICER | -75.00K | $26.53 | -$1.99M | SELL | -2.26% | 3.24M | Jun 23 | View |
| Jun 23, 2021 | Michael Andrew Schemick | CHIEF FINANCIAL OFFICER | -66.67K | $26.94 | -$1.80M | SELL | -7.43% | 830.18K | Jun 22 | View |
| Jun 17, 2021 | Justin Edge | PRES., REGULATORY & ACCESS | -5.00K | $27.02 | -$135.07K | SELL | -1.11% | 447.09K | Jun 16 | View |
| Jun 15, 2021 | Robert Aspbury | PRESIDENT, SIMCYP | -19.35K | $27.59 | -$533.91K | SELL | -4.94% | 372.44K | Jun 14 | View |
| Jun 15, 2021 | Craig R Rayner | PRESIDENT, INTEGRATED DRUG DEV | -108.92K | $25.71 | -$2.80M | SELL | -22.72% | 370.47K | Jun 11 | View |
| Mar 30, 2021 | EQT Avatar Parent LPEQT Avatar Parent GP LLCrl Sa Management Fund EQT | 10% OWNER | -8.67M | $24.13 | -$209.26M | SELL | -11.58% | 66.22M | Mar 29 | View |
| Dec 16, 2020 | MATTHEW WALSH | — | 172.90K | $23.00 | $115.00K | GRANT OR AWARD | ∞ | 172.90K | Dec 10 - Dec 15 | View |
| Dec 16, 2020 | EQT Avatar Parent LPEQT Avatar Parent GP LLCrl Sa Management Fund EQT | — | -14.17M | $21.62 | -$306.31M | SELL | -15.91% | 74.90M | Dec 15 | View |
| Dec 16, 2020 | JAMES CASHMAN III | — | 476.72K | $23.00 | $460.00K | GRANT OR AWARD | ∞ | 476.72K | Dec 10 - Dec 15 | View |
| Dec 16, 2020 | Stephen McLean | — | 22.00K | $23.00 | $506.00K | PURCHASE | ∞ | 22.00K | Dec 15 | View |
| Dec 16, 2020 | Richard M. Traynor Richard M. Traynor | — | 341.80K | $23.00 | $5.63K | GRANT OR AWARD | ∞ | 341.80K | Dec 10 - Dec 15 | View |
FAQ
Is insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.